Previous
Previous
Eviva Partners is linked by the New York Times
Next
Next
Alex Morozov is a physician, scientist and drug developer with a passion for improving health outcomes and reducing care gaps in every community around the world. He is the CEO and founder of Eviva Partners, a nonprofit promoting better understanding of evidence through education and behavioral science approaches for both patients and providers, while characterizing and monitoring improvement in care gaps (defined as both underuse and overuse).
Alex obtained his undergraduate degree from MIT, followed by combined MD-PhD training at the Albert Einstein College of Medicine in New York. After internal medicine residency at Columbia-Presbyterian and medical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York, Alex was recruited by a friend to join the pharmaceutical industry. Over his 14-year drug development career, Alex has designed, conducted and overseen hundreds of clinical trials, leading to regulatory approval of several new cancer therapies by the FDA and other health authorities around the world. Following his interest in data and digital innovation, he led teams developing and implementing new technologies to accelerate clinical trials, address health equity, and improve outcomes for patients in clinical practice.
He is working on a book called “The Language of Evidence: Getting Well in a World Without Proof,” from which portions of this essay are adopted.